비교리스트

 카트 문의
시장보고서
상품코드
1463045

인간성장호르몬 시장 점유율, 규모, 동향, 산업 분석 보고서 : 유형별, 투여 경로별, 연령별, 적응증별, 유통 채널별, 지역별, 부문별 예측(2024-2032년)

Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 114 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 연구에 따르면, 인간성장호르몬 세계 시장 규모는 2032년까지 156억 6,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

인간성장호르몬(HGH) 시장의 범위는 그 범위, 용도 및 영향요인을 정의하는 다양한 차원을 포괄합니다. 이 시장은 소아 및 성인의 성장호르몬 결핍과 같은 질병에 대한 HGH의 치료 용도를 다루고 있으며, 내인성 성장호르몬 분비가 불충분한 사람의 성장과 발달을 촉진하기 위해 HGH를 사용합니다.

시장의 대부분은 성장호르몬 결핍으로 인한 저신장증과 같은 상태를 포함한 소아 성장 장애에 대응하는 데 초점을 맞추고 있으며, HGH 치료는 어린이의 선형 성장을 촉진하는 일반적인 치료법입니다. 이 시장은 성장호르몬 결핍증을 앓고 있는 성인에게도 확대되고 있으며, HGH는 AGHD와 같은 질환을 치료하는 데 사용되고 있습니다. 여기에는 성인기 성장호르몬 분비 부족과 관련된 건강 문제를 해결하는 것이 포함됩니다. 시장에는 노화 방지 및 웰니스 분야도 점점 더 많이 등장하고 있으며, HGH는 피부 건강, 에너지 수준 및 전반적인 건강 개선과 같은 노화 방지 효과로 인식되기 위해 사용되기도 합니다.

또한, HGH는 근육 약화 및 대사 장애를 치료하는 데에도 사용되고 있습니다. 이 시장은 특정 환자 집단에서 근육 감소의 영향을 완화하고 대사 기능을 개선하기 위해 HGH의 치료적 사용을 위해 노력하고 있습니다.

성장호르몬 결핍증(GHD)의 높은 유병률, GHD와 관련된 심각한 위험으로 인한 치료의 필요성 증가, 주사 빈도를 줄이는 약물에 대한 수요 증가는 인간성장호르몬 시장의 성장에 기여하는 주요 요인입니다.

뇌하수체 기능 부전 사례의 증가와 환자의 치료 순응도를 높이기 위한 첨단 기술의 시장 개척과 같은 요인도 시장 성장에 기여하고 있습니다. 소마토트로핀의 강력한 파이프라인과 함께 업계 업체들의 연구개발 활동에 대한 집중적인 노력은 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

적절한 치료와 관련된 인식의 증가와 인간 성장 부전 치료와 관련된 공공 및 민간 기관의 이니셔티브가 증가함에 따라 인간성장호르몬 시장 확대에 도움이 될 것으로 예상됩니다. 또한, 신흥국 전반에 걸쳐 희귀 질환을 앓고 있는 환자 수가 증가하고 있는 것도 시장 확대에 기여할 것으로 보입니다.

인간성장호르몬 시장 보고서 하이라이트

장시간 작용형 인간성장호르몬의 안전성 프로파일과 효능으로 인해 장시간 작용형 부문은 예측 기간 동안 가장 높은 CAGR로 확대될 것으로 예상됩니다.

2023년에는 성장호르몬 결핍증 분야가 가장 큰 시장 점유율을 차지했는데, 이는 성장호르몬 결핍증의 높은 유병률과 치료용 신제품의 증가에 기인한 것으로 분석됐습니다.

2023년 병원 약국 부문은 병원 방문 환자 수 증가로 인해 가장 큰 시장 점유율을 차지했습니다.

북미는 터너 증후군과 성장호르몬 결핍증 사례가 증가함에 따라 2023년 인간성장호르몬 시장에서 가장 큰 매출 점유율을 차지했습니다.

시장 기업으로는 AnkeBio Co., Ltd., Ascendis Pharma, Novo Nordisk, Pfizer, Eli Lilly, Sandoz International, Merck, Genentech 등이 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 인간성장호르몬 시장 인사이트

  • 인간성장호르몬 - 업계 현황
  • 인간성장호르몬 시장 역학
    • 성장 촉진요인과 기회
      • 성장호르몬결핍증 및 기타 질환 이환율 상승
      • 연구개발 활동 증가
    • 성장 억제요인과 과제
      • 부작용과 안전성 우려
  • PESTLE 분석
  • 인간성장호르몬 업계 동향
  • COVID-19의 영향 분석

제5장 유형별 세계 시장

  • 주요 조사 결과
  • 소개
  • 장시간 작용형
  • 단시간 작용형과 중시간 작용형

제6장 투여 경로별 세계 시장

  • 주요 조사 결과
  • 소개
  • 경구
  • 비경구

제7장 연령별 세계 시장

  • 주요 조사 결과
  • 소개
  • 소아
  • 성인

제8장 유통 채널별 세계 시장

  • 주요 조사 결과
  • 소개
  • 병원 약국
  • 소매 약국·드럭스토어
  • 온라인 약국

제9장 적응증별 세계 시장

  • 주요 조사 결과
  • 소개
  • 성장호르몬결핍증
  • 터너 증후군
  • 특발성 저신장
  • 프라더 윌리 증후군
  • 기타

제10장 지역별 세계 시장

  • 주요 조사 결과
  • 소개
    • 인간성장호르몬 시장 평가, 지역별, 2019-2032년
  • 인간성장호르몬 시장 - 북미
    • 북미 : 인간성장호르몬 시장, 유형별, 2019-2032년
    • 북미 : 인간성장호르몬 시장, 유통 채널별, 2019-2032년
    • 북미 : 인간성장호르몬 시장, 투여 경로별, 2019-2032년
    • 북미 : 인간성장호르몬 시장, 연령별, 2019-2032년
    • 북미 : 인간성장호르몬 시장, 적응증별, 2019-2032년
    • 인간성장호르몬 시장 - 미국
    • 인간성장호르몬 시장 - 캐나다
  • 인간성장호르몬 시장 - 유럽
    • 유럽 : 인간성장호르몬 시장, 유형별, 2019-2032년
    • 유럽 : 인간성장호르몬 시장, 유통 채널별, 2019-2032년
    • 유럽 : 인간성장호르몬 시장, 투여 경로별, 2019-2032년
    • 유럽 : 인간성장호르몬 시장, 연령별, 2019-2032년
    • 유럽 : 인간성장호르몬 시장, 적응증별, 2019-2032년
    • 인간성장호르몬 시장 - 영국
    • 인간성장호르몬 시장 - 프랑스
    • 인간성장호르몬 시장 - 독일
    • 인간성장호르몬 시장 - 이탈리아
    • 인간성장호르몬 시장 - 스페인
    • 인간성장호르몬 시장 - 네델란드
    • 인간성장호르몬 시장 - 러시아
  • 인간성장호르몬 시장 - 아시아태평양
    • 아시아태평양 : 인간성장호르몬 시장, 유형별, 2019-2032년
    • 아시아태평양 : 인간성장호르몬 시장, 유통 채널별, 2019-2032년
    • 아시아태평양 : 인간성장호르몬 시장, 투여 경로별, 2019-2032년
    • 아시아태평양 : 인간성장호르몬 시장, 연령별, 2019-2032년
    • 아시아태평양 : 인간성장호르몬 시장, 적응증별, 2019-2032년
    • 인간성장호르몬 시장 - 중국
    • 인간성장호르몬 시장 - 인도
    • 인간성장호르몬 시장 - 일본
    • 인간성장호르몬 시장 - 말레이시아
    • 인간성장호르몬 시장 - 인도네시아
    • 인간성장호르몬 시장 - 한국
  • 인간성장호르몬 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 인간성장호르몬 시장, 유형별, 2019-2032년
    • 중동 및 아프리카 : 인간성장호르몬 시장, 유통 채널별, 2019-2032년
    • 중동 및 아프리카 : 인간성장호르몬 시장, 투여 경로별, 2019-2032년
    • 중동 및 아프리카 : 인간성장호르몬 시장, 연령별, 2019-2032년
    • 중동 및 아프리카 : 인간성장호르몬 시장, 적응증별, 2019-2032년
    • 인간성장호르몬 시장 - 사우디아라비아
    • 인간성장호르몬 시장 - UAE
    • 인간성장호르몬 시장 - 이스라엘
    • 인간성장호르몬 시장 - 남아프리카
  • 인간성장호르몬 시장 - 라틴아메리카
    • 라틴아메리카 : 인간성장호르몬 시장, 유형별, 2019-2032년
    • 라틴아메리카 : 인간성장호르몬 시장, 유통 채널별, 2019-2032년
    • 라틴아메리카 : 인간성장호르몬 시장, 투여 경로별, 2019-2032년
    • 라틴아메리카 : 인간성장호르몬 시장, 연령별, 2019-2032년
    • 라틴아메리카 : 인간성장호르몬 시장, 적응증별, 2019-2032년
    • 인간성장호르몬 시장 - 멕시코
    • 인간성장호르몬 시장 - 브라질
    • 인간성장호르몬 시장 - 아르헨티나

제11장 경쟁 상황

  • 확대와 인수 분석
    • 확대
    • 인수
  • 파트너십/협업/계약/공개

제12장 기업 개요

  • AnkeBio Co., Ltd
  • Ascendis Pharma
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • Genentech, Inc(Roche)
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sandoz International GmbH
ksm 24.05.14

The global human growth hormone market size is expected to reach USD 15.66 billion by 2032, according to a new study by Polaris Market Research. The report "Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The scope of the Human Growth Hormone (HGH) market encompasses various dimensions that define its reach, applications, and influencing factors. The market caters to therapeutic applications of HGH, addressing medical conditions such as growth hormone deficiencies in children and adults. HGH is used to stimulate growth and development in individuals with insufficient endogenous growth hormone production.

A significant portion of the market focuses on addressing pediatric growth disorders, including conditions like short stature due to growth hormone deficiencies. HGH therapy is a common intervention to promote linear growth in children. The market extends its scope to adults with growth hormone deficiencies, where HGH is used to address conditions such as AGHD. This involves addressing health issues associated with insufficient growth hormone production in adulthood. There is a growing segment within the market that caters to anti-aging and wellness applications. HGH is sometimes used for its perceived anti-aging effects, including improvements in skin health, energy levels, and overall well-being.

Furthermore, HGH is employed in the treatment of muscle-wasting conditions and metabolic disorders. The market addresses the therapeutic use of HGH to mitigate the effects of muscle loss and improve metabolic functions in certain patient populations.

The high prevalence of growth hormone deficiency (GHD), the increasing need for treatment owing to serious risks associated with GHD, and the rising demand for medications that reduce the frequency of injections are the major factors contributing to the growth of the human growth hormone market.

Factors such as increasing cases of pituitary dysfunction and the development of more advanced technologies to enhance patient adherence to the treatment contribute to the market growth. The rising emphasis of industry players on research & development activities coupled with the strong pipeline of somatropin is expected to drive the market growth during the forecast period.

Increasing awareness related to appropriate treatment coupled with the growing initiatives by public and private organizations related to the treatment of human growth deficiency are expected to prove beneficial for the expansion of the human growth hormone market. Moreover, the increasing number of patients suffering from rare diseases across developing countries will also contribute to the market growth.

Human Growth Hormone Market Report Highlights

The long-acting segment is projected to expand at the highest CAGR during the forecast period, owing to the safety profile & effectiveness of long-acting human growth hormones.

In 2023, the growth hormone deficiency segment accounted for the largest market share, owing to the high prevalence of the disease and the rising number of new products for its treatment.

In 2023, the hospital pharmacies segment accounted for the largest market share, owing to the increasing number of patient visits to hospitals.

North America accounted for the largest revenue share in the human growth hormone market in 2023, owing to the rising cases of Turner syndrome and growth hormone deficiencies.

The market players include AnkeBio Co., Ltd, Ascendis Pharma, Novo Nordisk, Pfizer, Eli Lilly, Sandoz International, Merck, Genentech, and more.

Polaris Market Research has segmented the human growth hormone market report based on type, route of administration, age, indication, distribution channel, and region:

Human Growth Hormone, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Long-acting
  • Short-acting & Intermediate-acting

Human Growth Hormone, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Human Growth Hormone, Age Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pediatric
  • Adult

Human Growth Hormone, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Others

Human Growth Hormone, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

Human Growth Hormone, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Growth Hormone Market Insights

  • 4.1. Human Growth Hormone - Industry Snapshot
  • 4.2. Human Growth Hormone Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Growth Hormone Deficiency and Other Disorders
      • 4.2.1.2. Growing Number of Research & Development Activities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Human Growth Hormone Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Human Growth Hormone Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Long-acting
    • 5.3.1. Global Human Growth Hormone Market, by Long-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Short-acting & Intermediate-acting
    • 5.4.1. Global Human Growth Hormone Market, by Short-acting & Intermediate-acting, by Region, 2019-2032 (USD Billion)

6. Global Human Growth Hormone Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Human Growth Hormone Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Parenteral
    • 6.4.1. Global Human Growth Hormone Market, by Parenteral, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Intravenous
      • 6.4.2.1. Global Human Growth Hormone Market, by Intravenous, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Subcutaneous
      • 6.4.3.1. Global Human Growth Hormone Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)
    • 6.4.4. Intramuscular
      • 6.4.4.1. Global Human Growth Hormone Market, by Intramuscular, by Region, 2019-2032 (USD Billion)

7. Global Human Growth Hormone Market, by Age

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • 7.3. Pediatric
    • 7.3.1. Global Human Growth Hormone Market, by Pediatric, by Region, 2019-2032 (USD Billion)
  • 7.4. Adult
    • 7.4.1. Global Human Growth Hormone Market, by Adult, by Region, 2019-2032 (USD Billion)

8. Global Human Growth Hormone Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Human Growth Hormone Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4. Retail Pharmacies & Drug Stores
    • 8.4.1. Global Human Growth Hormone Market, by Retail Pharmacies & Drug Stores, by Region, 2019-2032 (USD Billion)
  • 8.5. Online Pharmacies
    • 8.5.1. Global Human Growth Hormone Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

9. Global Human Growth Hormone Market, by Indication

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 9.3. Growth Hormone Deficiency
    • 9.3.1. Global Human Growth Hormone Market, by Growth Hormone Deficiency, by Region, 2019-2032 (USD Billion)
  • 9.4. Turner Syndrome
    • 9.4.1. Global Human Growth Hormone Market, by Turner Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.5. Idiopathic Short Stature
    • 9.5.1. Global Human Growth Hormone Market, by Idiopathic Short Stature, by Region, 2019-2032 (USD Billion)
  • 9.6. Prader-Willi Syndrome
    • 9.6.1. Global Human Growth Hormone Market, by Prader-Willi Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.7. Others
    • 9.7.1. Global Human Growth Hormone Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Human Growth Hormone Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Human Growth Hormone Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Human Growth Hormone Market - North America
    • 10.3.1. North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.3. North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.4. North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.3.5. North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.6. Human Growth Hormone Market - U.S.
      • 10.3.6.1. U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.7. Human Growth Hormone Market - Canada
      • 10.3.7.1. Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.4. Human Growth Hormone Market - Europe
    • 10.4.1. Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.6. Human Growth Hormone Market - UK
      • 10.4.6.1. UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.7. Human Growth Hormone Market - France
      • 10.4.7.1. France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.8. Human Growth Hormone Market - Germany
      • 10.4.8.1. Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.9. Human Growth Hormone Market - Italy
      • 10.4.9.1. Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.10. Human Growth Hormone Market - Spain
      • 10.4.10.1. Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.11. Human Growth Hormone Market - Netherlands
      • 10.4.11.1. Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.12. Human Growth Hormone Market - Russia
      • 10.4.12.1. Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.5. Human Growth Hormone Market - Asia Pacific
    • 10.5.1. Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.6. Human Growth Hormone Market - China
      • 10.5.6.1. China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.7. Human Growth Hormone Market - India
      • 10.5.7.1. India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.8. Human Growth Hormone Market - Japan
      • 10.5.8.1. Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.9. Human Growth Hormone Market - Malaysia
      • 10.5.9.1. Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.10. Human Growth Hormone Market - Indonesia
      • 10.5.10.1. Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.11. Human Growth Hormone Market - South Korea
      • 10.5.11.1. South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.6. Human Growth Hormone Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.6. Human Growth Hormone Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.7. Human Growth Hormone Market - UAE
      • 10.6.7.1. UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.8. Human Growth Hormone Market - Israel
      • 10.6.8.1. Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.9. Human Growth Hormone Market - South Africa
      • 10.6.9.1. South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.7. Human Growth Hormone Market - Latin America
    • 10.7.1. Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.6. Human Growth Hormone Market - Mexico
      • 10.7.6.1. Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.7. Human Growth Hormone Market - Brazil
      • 10.7.7.1. Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.8. Human Growth Hormone Market - Argentina
      • 10.7.8.1. Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AnkeBio Co., Ltd
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Ascendis Pharma
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Ferring Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Genentech, Inc (Roche)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Merck KGaA
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Novo Nordisk
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Pfizer Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Sandoz International GmbH
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제